Follow last change Sep 2012 re-read 3 minutes ago

D4T

also known as stavudine

Developed for: AIDS · lactic acidosis
Investigated by: CIHR Canadian HIV Trials Network · GlaxoSmithKline · Ministry of Science and Technology of the People´s Republic of China · Peking Union Medical College · University of British Columbia

today NCT00872417 · Ph 4 NCT00143702 · Ph 2/3

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2/31 trial
Phase 2/3	NCT00143702	Aug 2001 → Aug 2006	lactic acidosis	University of British Columbia	Completed	No outcome recorded
Phase 41 trial
Phase 4	NCT00872417	Mar → Dec 2009	AIDS	Peking Union Medical College	Unknown	No outcome recorded
Comparator or background therapy2 trials
Phase 2	NCT00651066 Background	Jun 2010 → Sep 2012	HIV infectious disease, tuberculosis	French National Agency for Research on AIDS and Viral Hepatitis	Completed	No outcome recorded
Phase 2	NCT00640887 Background	Feb 2009 → Oct 2010	HIV infectious disease, tuberculosis	French National Agency for Research on AIDS and Viral Hepatitis	Completed	No outcome recorded

Every value below carries the sentence it was read from. 4 sources stand behind the page.

Field	Value	Cited text
Known as	d4T	“3TC(300mg)/D4t(60mg)/LPV/r(800mg/200mg)+INH/PZA/EMT/Rifabutin(150 mg TPW 3 wks switch to 150 mg OD 4 wks);” NCT00651066 ↗ 3 “D4T/3TC/EFV(600mg)+INH/Rifabutin(450 mg OD 4 wks switch to 600 mg OD 4 wks)” NCT00640887 ↗ NCT00143702 ↗ NCT00872417 ↗
Known as	stavudine	“d4T (stavudine)” NCT00143702 ↗